Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Lassen

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Seminars in Thrombosis and Hemostasis|September 30, 2000
Comparative efficacy of low-molecular-weight heparins in orthopedic surgeryM R Lassen
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2012
Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacementM R Lassen
Current Opinion in Pulmonary Medicine|July 1, 1996
Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgeryM R Lassen, L C Borris
Orthopedics|May 16, 2014
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Haemostasis|March 1, 1993
Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studiesL C Borris, M R Lassen
Orthopedics|February 1, 1997
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Drugs|January 1, 1996
Thromboprophylaxis with low molecular weight heparin after major orthopaedic surgery is cost effectiveL C Borris, M R Lassen
Drug Safety|January 1, 1995
A comparative review of the adverse effect profiles of heparins and heparinoidsL C Borris, M R Lassen
Ugeskrift for Laeger|May 22, 1989
[Low-molecular weight heparin. A new agent to prevent thrombosis]H M Christiansen, L C Borris, M R Lassen
Acta Orthopaedica Scandinavica|December 1, 1987
Elbow dislocation in children and adults. A long-term follow-up of conservatively treated patientsL C Borris, M R Lassen, C S Christensen
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Seminars in Thrombosis and Hemostasis|September 30, 2000
Comparative efficacy of low-molecular-weight heparins in orthopedic surgeryM R Lassen
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2012
Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacementM R Lassen
Current Opinion in Pulmonary Medicine|July 1, 1996
Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgeryM R Lassen, L C Borris
Orthopedics|May 16, 2014
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Haemostasis|March 1, 1993
Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studiesL C Borris, M R Lassen
Orthopedics|February 1, 1997
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Drugs|January 1, 1996
Thromboprophylaxis with low molecular weight heparin after major orthopaedic surgery is cost effectiveL C Borris, M R Lassen
Drug Safety|January 1, 1995
A comparative review of the adverse effect profiles of heparins and heparinoidsL C Borris, M R Lassen
Ugeskrift for Laeger|May 22, 1989
[Low-molecular weight heparin. A new agent to prevent thrombosis]H M Christiansen, L C Borris, M R Lassen
Acta Orthopaedica Scandinavica|December 1, 1987
Elbow dislocation in children and adults. A long-term follow-up of conservatively treated patientsL C Borris, M R Lassen, C S Christensen
Pageof 7